Application for a reference to the European Court of Justice in an action in which the Claimant (ViiV) seeks a declaration as to the proper interpretation of Article 3 of the Regulation in the context of a Supplementary Protection Certificate granted in 2005 in respect of ‘A combination comprising abacavir, optionally in the form of a physiologically functional derivative and lamivudine, optionally in the form of a physiologically functional derivative.’
John Baldwin QC HHJ
[2015] EWHC 1074 (Ch)
Bailii
Regulation (EC) No 469/2009 3
England and Wales
European, health
Updated: 29 December 2021; Ref: scu.545927
